Tuberculosis for MRCP: The Complete Guidelines Masterclass
Tuberculosis is one of those rare topics that touches every single component of the MRCP — Part 1 pharmacology loves rifampicin interactions, Part 2 loves the chest X-ray, CSF and sputum datasets, and PACES loves the six-month adherence consultation. England still notifies over 4,000 new cases every year, and notifications have climbed again since the pandemic, so TB is a live clinical problem — not an exam relic. Everything below is mapped to NICE guideline NG33, the document UK examiners build their mark schemes around.
Why TB Is Guaranteed Marks
Crosses disciplines: respiratory, infectious diseases, pharmacology, public health, ethics and communication all in one topic
High-frequency exam stems: night sweats and weight loss, deranged LFTs on treatment, sterile pyuria, basal meningitis
PACES favourite: counselling the newly diagnosed patient, managing side effects, discussing family screening
Pathology in 90 Seconds
Primary TB: first exposure produces a subpleural Ghon focus (mid/lower zone) plus draining hilar lymphadenopathy — the Ranke complex when calcified. It usually heals, but viable bacilli persist as latent infection.
Post-primary (reactivation) TB: occurs in the apical and posterior segments of the upper lobes — high oxygen tension favours reactivation. Cavitation is the radiological hallmark.
Haematogenous spread: miliary TB and seeding of the adrenals, bones, genitourinary tract and CNS.
Immune phenomena: erythema nodosum and phlyctenular conjunctivitis.
Risk factors examiners expect you to list unprompted: HIV, anti-TNF therapy and other immunosuppression, dialysis/CKD, diabetes, silicosis, malnutrition and vitamin D deficiency, alcohol excess, homelessness and prison, and birth or prolonged residence in a high-incidence country.
Classic exam trigger: commencing anti-TNF therapy — you must screen for and treat latent TB before starting the biologic.
Latent vs Active TB: Get the Framework Right
| Feature | Latent TB | Active TB |
|---|---|---|
| Symptoms | None | Cough >3 weeks, haemoptysis, fever, night sweats, weight loss |
| Infectivity | Not infectious | Pulmonary and laryngeal disease contagious |
| Chest X-ray | Normal or old scarring | Opacification, cavitation, effusion, miliary nodules |
| Diagnostic test | IGRA ± Mantoux | Sputum AFB/culture/Xpert, histology |
Testing for latent TB
IGRA is first-line in those aged 5 and over — it is unaffected by prior BCG vaccination
Mantoux (positive ≥5 mm induration) remains first-line in children under 5, with both tests recommended in immunosuppressed patients
Offer latent TB testing to: contacts of smear-positive cases, new entrants under 65 from high-incidence countries (≥150 per 100,000), people living with HIV, patients before anti-TNF therapy, and dialysis patients
Treating latent TB
3 months of isoniazid + rifampicin (3HR) or 6 months of isoniazid (6H); 4 months of rifampicin alone is a recognised alternative
Always exclude active disease first — treating miliary TB with only two drugs is a potentially fatal error
Diagnosing Active Pulmonary TB
Three sputum samples, at least one early morning, for AFB microscopy, mycobacterial culture (solid Löwenstein–Jensen medium takes up to 6 weeks; liquid MGIT around 2 weeks) and Xpert MTB/RIF Ultra — a same-day PCR that also detects rifampicin resistance
Chest X-ray: upper-zone shadowing ± cavitation; finely nodular miliary pattern; scrutinise the apices
Always test for HIV, and consider hepatitis B/C and diabetes screening
If clinical suspicion is high, start empirical treatment while awaiting culture — never wait six weeks in a sick patient
Histology shows caseating granulomas (contrast with non-caseating granulomas of sarcoidosis)
Extrapulmonary quick-reference
Lymph node (scrofula): commonest extrapulmonary site
Pleural: lymphocyte-rich exudative effusion; pleural biopsy is more sensitive than fluid culture
Skeletal: Pott's disease of the spine — vertebral collapse, paravertebral cold abscess, psoas abscess
Genitourinary: sterile pyuria — send three early-morning urines for AFB
CNS: basal meningitis (CSF shows high protein, very low glucose, lymphocytosis), tuberculomas, hydrocephalus, basal ganglia infarction
Pericardial: effusion progressing to constrictive pericarditis
Adrenal: a recognised cause of primary adrenal insufficiency
Miliary: look for choroidal tubercles on fundoscopy
Treatment: The RIPE Regimen
Standard therapy: 2 months of rifampicin + isoniazid + pyrazinamide + ethambutol, followed by 4 months of rifampicin + isoniazid — six months in total.
| Drug | Signature toxicity | Exam pearl |
|---|---|---|
| Rifampicin | Hepatitis; orange staining of all body fluids | Potent CYP450 inducer — the interaction question |
| Isoniazid | Peripheral neuropathy, hepatitis, lupus-like syndrome, sideroblastic anaemia | Give pyridoxine (vitamin B6), especially in diabetes, pregnancy, HIV, CKD and alcohol excess |
| Pyrazinamide | Hepatitis (the most hepatotoxic), hyperuricaemia and gout | Confined to the intensive phase |
| Ethambutol | Dose-dependent optic neuritis — reduced acuity, red–green colour desaturation | Baseline Snellen acuity; dose-reduce in renal impairment |
Duration adjustments
CNS TB: 12 months of treatment plus dexamethasone
Pericardial TB: 6 months plus prednisolone
Bone and joint TB: 6 months with specialist input
Special situations
Pregnancy and breastfeeding: treat with the standard four-drug regimen (all considered safe); avoid streptomycin (fetal ototoxicity)
HIV co-infection: treat TB promptly; ART is usually started within weeks (earlier when CD4 is very low); anticipate immune reconstitution inflammatory syndrome (IRIS) and major rifampicin–antiretroviral interactions
Jaundice or symptomatic hepatitis on treatment: stop the hepatotoxic drugs, involve TB services and microbiology, and reintroduce agents sequentially — never silently continue
Adherence problems: arrange directly observed therapy (DOT), often as supervised thrice-weekly dosing
Monitoring on treatment
Baseline FBC, U&E, LFTs, HIV test, hepatitis serology, HbA1c, visual acuity and weight (dosing is weight-based)
Monthly clinical review; repeat LFTs if nausea, jaundice or right upper quadrant pain develops, or if baseline risk is high
Monthly sputum until culture-negative, with follow-up for 12 months after completion
The Rifampicin Interaction Trap (Part 1 Gold)
Rifampicin powerfully induces hepatic CYP450 enzymes and reduces levels of:
Combined oral contraceptive pill — advise barrier contraception (the single most tested interaction)
Warfarin — INR falls; intensify monitoring
Sulfonylureas, levothyroxine and corticosteroids
Tacrolimus and ciclosporin, azole antifungals, HIV protease inhibitors
Methadone — can precipitate acute withdrawal
DOACs — avoid combinations where possible
Also warn patients that orange discolouration of urine, sweat and tears is expected — soft contact lenses may become permanently stained.
Public Health Duties You Must Verbalise in PACES
TB is a notifiable disease: suspected and confirmed cases must be notified to the local UKHSA health protection team — a legal duty under the Health Protection (Notification) Regulations 2010
TB services coordinate contact tracing and screening of close contacts of smear-positive pulmonary cases
BCG (a live vaccine) is contraindicated in known HIV-positive individuals
Isolate suspected pulmonary TB while infectivity is assessed; negative-pressure isolation if MDR-TB is possible
MDR-TB in a Paragraph
Resistance to isoniazid plus rifampicin defines MDR-TB; additional resistance to a fluoroquinolone and an injectable defines XDR-TB. A positive Xpert rifampicin-resistance result implies roughly a 90% probability of MDR-TB — escalate urgently to a specialist centre, never add a single drug to a failing regimen, and expect prolonged regimens containing agents such as bedaquiline, delamanid, linezolid and clofazimine.
How TB Appears in PACES
Station 5: counselling a new diagnosis — deliver the diagnosis with empathy, explain the six-month duration, side effects (including orange urine), family screening, notification, and adherence strategies. Variants include the patient with jaundice on treatment, or hazardous alcohol use compounding hepatotoxicity risk
Station 1: thoracoplasty scar, apical fibrosis, post-TB bronchiectasis, or an aspergilloma within an old cavity
Station 2: chronic cough with night sweats and weight loss — the differential you must actively construct
Ten High-Yield One-Liners
Sterile pyuria in a high-risk patient means early-morning urines for AFB
Anti-TNF therapy starts only after latent TB has been excluded or treated
Caseating granulomas mean TB; non-caseating mean sarcoidosis
Document Snellen acuity before ethambutol; red–green desaturation is the early sign of optic neuritis
Pyridoxine prevents isoniazid-induced peripheral neuropathy
Orange tears and urine mean rifampicin — and stained contact lenses
Contraceptive failure on rifampicin is the classic Part 1 stem
CSF with high protein, very low glucose and lymphocytes equals TB meningitis: 12 months of treatment plus dexamethasone
Pericardial TB receives prednisolone; CNS TB receives dexamethasone
Upper-zone fibrosis differential: old TB, sarcoidosis, silicosis, radiotherapy, ankylosing spondylitis
Key Takeaways
Master latent versus active disease: IGRA and who to test versus three sputums and Xpert
Know the RIPE regimen — 2 months of four drugs, 4 months of two — plus the CNS (12 months, dexamethasone) and pericardial (6 months, prednisolone) exceptions
The side-effect table (neuropathy, optic neuritis, hepatitis, gout) and the rifampicin interaction list are repeated exam currency
Notification and contact tracing are clinical duties, not optional extras — say them out loud in PACES
Approach TB as a connected story — risk factors, testing, treatment, toxicity, public health — and you will convert one of the commonest clinical scenarios in UK practice into reliable marks in every component of the MRCP.
Join the Discussion
Share your thoughts and insights with the medical community
Comments
Delete Comment
Are you sure you want to delete this comment? This action cannot be undone.